Access
To read this story in full you will need to login or make a payment (see right).
Sponsor's Foreword
Nature Medicine 8, 1208 (2002)
doi:10.1038/nm1102-1208
From the sponsors
Eleanor A. O'Rangers1
- Senior Medical Marketing Leader, Dyslipidemia AstraZeneca LP Wayne, Pennsylvania, USA
Abstract
AstraZeneca LP is a proud sponsor of Nature Medicine's new innovative feature, 'Special Focus on Atherosclerosis'.
Atherosclerotic coronary artery disease remains the leading cause of death despite many advances in our scientific understanding of this disease process and its pharmacological management. Atherosclerosis may be viewed as a more intricate process than merely the passive deposition of fat in arteries.
To read this story in full you will need to login or make a payment (see right).
